← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M

$ Value

Shares

990

Price

Filed

Apr 29

Insider

Name

Ragosa Mark

Title

CHIEF FINANCIAL OFFICER

CIK

0001835458

Roles

Officer

Transaction Details

Transaction Date

2025-04-26

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,488

Footnotes

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 26, 2021.

Filing Info

Accession No.

0001415889-25-011502

Form Type

4

Issuer CIK

0001730430

Ragosa Mark's History

Date Ticker Type Value
2026-04-07 KNSA M
2026-04-07 KNSA F $64K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $121K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07